Digest Network Come funziona
Network
/
Società
Av
Non verificato

Avenacy

Di cosa scriviamo

BiotecnologiaEventiFarmaceuticaSaluteSanità

20 comunicati stampa

Guarda tutti i comunicati
03/12/2025
Farmaceutica
Salute
Sanità
Attrezzature medico-sanitarie
Eventi
Industria
Avenacy to Attend 2025 ASHP Midyear Clinical Meeting and Exhibition
Fonte
Avenacy
Emittente
Business Wire
1.00
0
22/10/2025
Eventi
Fiere
Salute
Farmaceutica
Avenacy to Highlight 2025 Achievements and Partnership Opportunities at CPHI Frankfurt
Fonte
Avenacy
Emittente
Business Wire
1.00
0
25/08/2025
Biotecnologia
Igiene alimentare
Salute
Industria
Vetrine/Shopping
Farmaceutica
Medicina - Varie
Infanzia
Sanità
Odontoiatria
Avenacy Announces Launch of Lidocaine Hydrochloride Injection, USP in the U.S. Market
Fonte
Avenacy
Emittente
Business Wire
1.00
0
21/07/2025
Avenacy Announces Launch of Dehydrated Alcohol Injection, USP Vials in the U.S. Market
Fonte
Avenacy
Emittente
Business Wire
1.00
0
24/06/2025
Biotecnologia
Farmaceutica
Salute
Mercato del lavoro
Avenacy Announces New Asset Based Lending Agreement with Texas Capital Bank
Fonte
Avenacy
Emittente
Business Wire
1.00
0
02/06/2025
Avenacy Announces Launch of Leuprolide Acetate Injection in the U.S. Market
Fonte
Avenacy
Emittente
Business Wire
1.00
0
27/05/2025
Avenacy Announces Launch of Doxycycline for Injection, USP in the U.S. Market
Fonte
Avenacy
Emittente
Business Wire
1.00
0
07/04/2025
Multimedialità
Industria
Biotecnologia
Igiene alimentare
Salute
Farmaceutica
Attrezzature medico-sanitarie
Avenacy Announces Launch of Propofol Injectable Emulsion, USP in the U.S. Market
Fonte
Avenacy
Emittente
Business Wire
1.00
0
17/03/2025
Avenacy Announces Launch of Five Injectable Antibiotic Products in the U.S. Market
Fonte
Avenacy
Emittente
Business Wire
1.00
0
10/03/2025
Eventi
Biotecnologia
Sanità
Salute
Farmaceutica
Attrezzature medico-sanitarie
Avenacy to Attend 2025 DCAT Week
Fonte
Avenacy
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0